subscribeSubscribe
Roche and KeChow Reach a Cooperation Agreement

Roche and KeChow Reach a Cooperation Agreement
PRNEWSWIRE
20 Aug 2021
Share Share
FDA Approves Atezolizumab Plus Cobimetinib and Vemurafenib for Advanced Melanoma

FDA Approves Atezolizumab Plus Cobimetinib and Vemurafenib for Advanced Melanoma
CANCERNETWORK
30 Jul 2020
Share Share
Roche`s Tecentriq, on top of targeted drugs, stalls melanoma

Roche`s Tecentriq, on top of targeted drugs, stalls melanoma
Carly Helfand FIERCE PHARMA
26 Apr 2020
Share Share
Roche`s phase III IMspire150 study of Tecentriq plus Cotellic & Zelboraf

Roche`s phase III IMspire150 study of Tecentriq plus Cotellic & Zelboraf
PHARMABIZ
13 Dec 2019
Share Share
HSE reimburses Braftovi combo

HSE reimburses Braftovi combo
Anna Smith PHARMA TIMES
23 Aug 2019
Share Share
Meet the protein responsible for nearly $100B in cancer drug deals

Meet the protein responsible for nearly $100B in cancer drug deals
Jacob Bell BIOPHARMADIVE
17 Aug 2019
Share Share
Roche/Exelixis` Cotellic fizzles in pivotal melanoma study

Roche/Exelixis` Cotellic fizzles in pivotal melanoma study
Natalie Grover ENDPTS
21 Jun 2019
Share Share
NICE recommends Pierre Fabre`s Braftovi in BRAF V600-mutated advanced melanoma

NICE recommends Pierre Fabre`s Braftovi in BRAF V600-mutated advanced melanoma
PHARMA FILE
22 Jan 2019
Share Share
Novartis wins key adjuvant Taf/Mek approval in Europe

Novartis wins key adjuvant Taf/Mek approval in Europe
Phil Taylor PM LIVE
29 Aug 2018
Share Share
Array scores FDA nod for Braftovi, Mektovi melanoma combo

Array scores FDA nod for Braftovi, Mektovi melanoma combo
E. Sagonowsky FIERCE PHARMA
28 Jun 2018
Share Share